1. Home
  2. STRA vs GLPG Comparison

STRA vs GLPG Comparison

Compare STRA & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STRA

Strategic Education Inc.

HOLD

Current Price

$80.68

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$28.35

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRA
GLPG
Founded
2017
1999
Country
United States
Belgium
Employees
N/A
704
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
STRA
GLPG
Price
$80.68
$28.35
Analyst Decision
Buy
Buy
Analyst Count
3
2
Target Price
$92.67
$36.50
AVG Volume (30 Days)
253.1K
192.2K
Earning Date
04-23-2026
05-06-2026
Dividend Yield
2.91%
N/A
EPS Growth
15.85
N/A
EPS
5.41
N/A
Revenue
$997,137,000.00
N/A
Revenue This Year
$3.93
N/A
Revenue Next Year
$4.93
N/A
P/E Ratio
$15.25
N/A
Revenue Growth
57.23
N/A
52 Week Low
$72.17
$23.37
52 Week High
$92.98
$37.78

Technical Indicators

Market Signals
Indicator
STRA
GLPG
Relative Strength Index (RSI) 45.06 31.36
Support Level $78.87 $26.62
Resistance Level $81.59 $33.67
Average True Range (ATR) 2.37 0.82
MACD -0.16 -0.11
Stochastic Oscillator 23.00 2.43

Price Performance

Historical Comparison
STRA
GLPG

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Share on Social Networks: